Louisiana State Employees Retirement System Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Louisiana State Employees Retirement System lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,200 shares of the medical equipment provider’s stock after selling 1,900 shares during the period. Intuitive Surgical accounts for 0.4% of Louisiana State Employees Retirement System’s holdings, making the stock its 25th biggest position. Louisiana State Employees Retirement System’s holdings in Intuitive Surgical were worth $23,593,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Leavell Investment Management Inc. lifted its holdings in shares of Intuitive Surgical by 0.7% during the fourth quarter. Leavell Investment Management Inc. now owns 3,556 shares of the medical equipment provider’s stock worth $1,856,000 after purchasing an additional 25 shares during the period. Portfolio Design Labs LLC raised its position in Intuitive Surgical by 14.7% during the 4th quarter. Portfolio Design Labs LLC now owns 4,035 shares of the medical equipment provider’s stock worth $2,106,000 after buying an additional 516 shares during the last quarter. New Republic Capital LLC lifted its stake in Intuitive Surgical by 34.9% during the 4th quarter. New Republic Capital LLC now owns 568 shares of the medical equipment provider’s stock valued at $296,000 after acquiring an additional 147 shares during the period. Sovran Advisors LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $250,000. Finally, Stonebridge Financial Group LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $343,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock valued at $3,587,582 over the last quarter. 0.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research reports. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Bernstein Bank boosted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Truist Financial raised their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Trading Down 0.7 %

Shares of Intuitive Surgical stock opened at $591.65 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The firm has a market capitalization of $210.73 billion, a PE ratio of 92.30, a P/E/G ratio of 5.67 and a beta of 1.39. The firm’s 50-day moving average price is $555.91 and its 200 day moving average price is $515.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.